Virus modified tumor cell vaccines for active specific immunotherapy of micrometastases: expansion and activation of tumor-specific T cells
Schirrmacher, V.; von Hoegen, P.; Heicappell, R.
Progress in Clinical and Biological Research 288: 391-399
1989
ISSN/ISBN: 0361-7742 PMID: 2785693 Document Number: 346823
Document emailed within 1 workday
Related Documents
Hanna, M.G.; Peters, L.C.; Hoover, H.C. 1989: Fundamentals of active specific immunotherapy of cancer using BCG-tumor cell vaccines Progress in Clinical and Biological Research 310: 51-65Grossmann, A.; Rameken, M.; Klapdor, R. 1997: Active-specific immunotherapy of pancreatic carcinoma: usefulness of human pancreatic carcinomas in preparing autologous tumor vaccines Anticancer Research 17(4b): 3117-3119
Raychaudhuri, S.; Saeki, Y.; Chen, J.J.; Iribe, H.; Fuji, H.; Kohler, H. 1987: Tumor-specific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2 beta) Journal of Immunology 139(1): 271-278
Mizushima, Y.; Sendo, F.; Miyake, T.; Kobayashi, H. 1981: Augmentation of specific cell-mediated immune responses to tumor cells in tumor-bearing rats pretreated wih the antileukemia drug busulfan Journal of the National Cancer Institute 66(4): 659-665
Naito, K.; Pellis, N.R.; Kahan, B.D. 1988: Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide Cancer Research 48(1): 101-108
Tuttle, T.M.; Inge, T.H.; Bethke, K.P.; McCrady, C.W.; Pettit, G.R.; Bear, H.D. 1992: Activation and growth of murine tumor-specific T-cells which have in vivo activity with bryostatin 1 Cancer Research 52(3): 548-553
Rahman, S.M.; Kawashima, K.; Nakashima, I.; Nagase, F. 1988: Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210 Cancer Research 48(22): 6450-6454
Kanner, S.B.; Parsons, S.J.; Parsons, J.T.; Gilmer, T.M. 1988: Activation of pp60c-src tyrosine kinase specific activity in tumor-derived Syrian hamster embryo cells Oncogene 2(4): 327-335
Koldovsky, P.; Weinstein, J. 1973: Expression of non-tumor-specific antigen in human tumor cells National Cancer Institute Monograph 37: 33-35
Maruno, K. 1990: Gastrin-releasing peptide as a specific tumor marker in patients with small cell lung carcinoma, compared with neuron-specific enolase Nihon Geka Gakkai Zasshi 91(6): 760-765
Mocellin, S. 2005: Priming anticancer active specific immunotherapy with dendritic cells Current Opinion in Investigational Drugs 6(6): 576-581
Maurer-Gebhard, M.; Schmidt, M.; Azemar, M.; Altenschmidt, U.; Stöcklin, E.; Wels, W.; Groner, B. 1998: Systemic treatment with a recombinant erbB-2 receptor-specific tumor toxin efficiently reduces pulmonary metastases in mice injected with genetically modified carcinoma cells Cancer Research 58(12): 2661-2666
Forman, J.; Ketchel, M.M. 1972: Resistance to non-strain-specific variant tumor cells by H-2 allogeneic mice receiving strain-specific cells Journal of the National Cancer Institute 48(4): 933-939
Matis, L.A.; Ruscetti, S.K.; Longo, D.L.; Jacobson, S.; Brown, E.J.; Zinn, S.; Kruisbeek, A.M. 1985: Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen Journal of Immunology 135(1): 703-713
Chida, K.; Hashiba, H.; Sasaki, K.; Kuroki, T. 1986: Activation of protein kinase C and specific phosphorylation of a Mr 90,000 membrane protein of promotable BALB/3T3 and C3H/10T1/2 cells by tumor promoters Cancer Research 46(3): 1055-1062
Akagi, T.; Ogawa, K. 1972: Relationship among tumorigenicity, T antigen, and virus-specific transplantation antigen in adenovirus type 12 transformed and tumor cells Gan 63(3): 307-312
Rohrer, J.W.; Rohrer, S.D.; Barsoum, A.; Coggin, J.H. 1994: Differential recognition of murine tumor-associated oncofetal transplantation antigen and individually specific tumor transplantation antigens by syngeneic cloned BALB/c and RFM mouse T cells Journal of Immunology 152(2): 754-764
Legrue, S.J.; Ananthaswamy, H.N.; Simcik, W.J. 1989: Afferent and efferent specificity in the induction and elicitation of parental cross-protective immunity by an immunogenic murine tumor variant: associative recognition of a unique tumor-specific antigen on somatic cell hybrids Cancer Research 49(17): 4747-4751
Thurnher, M.; Papesh, C.; Ramoner, R.; Gastl, G.; Böck, G.; Radmayr, C.; Klocker, H.; Bartsch, G. 1997: In vitro generation of CD83+ human blood dendritic cells for active tumor immunotherapy Experimental Hematology 25(3): 232-237
Bast, R.C.; Knapp, R.C.; Mitchell, A.K.; Thurston, J.G.; Tucker, R.W.; Schlossman, S.F. 1979: Immunotherapy of a murine ovarian carcinoma with Corynebacterium parvum and specific heteroantiserum. I. Activation of peritoneal cells to mediate antibody-dependent cytotoxicity Journal of Immunology 123(5): 1945-1951